Advertisement
Product › Details
DRUGS, GENERICS
Next higher product group | pharmaceutical | |
Record changed: 2023-10-04 |
Advertisement
More documents for DRUGS, GENERICS
- [1] Sandoz Group AG. (10/4/23). "Press Release: Sandoz Enters New Era as Standalone Global Leader and European Champion in Generic and Biosimilar Medicines". Basel....
- [2] EQL Pharma AB. (3/13/23). "Press Release: EQL Pharma Recruits Carl Lindgren as Chief Business Development Officer"....
- [3] Novartis AG. (8/25/22). "Press Release: Novartis Announces Intention to Separate Sandoz Business to Create a Standalone Company by Way of a 100% Spin-off". Basel....
- [4] Merck KGaA. (31/3/20). "Press Release: Merck Successfully Divests Allergopharma". Darmstadt....
- [5] Merck KGaA. (2/19/20). "Press Release: Merck Divests Allergopharma to Dermapharm Holding SE". Darmstadt....
- [6] Teva Pharmaceutical Industries Ltd.. (11/7/19). "Press Release: Teva Announces Appointment of New Chief Financial Officer". Jerusalem....
- [7] Sanofi S.A.. (10/1/18). "Press Release: Sanofi Completes Divestiture of Zentiva to Advent". Paris....
- [8] Novartis AG. (9/6/18). "Press Release: Novartis to Divest the Sandoz US Dermatology Business and Generic US Oral Solids Portfolio to Aurobindo". Basel....
- [9] c-LEcta GmbH. (2/8/18). "Press Release: c-LEcta Closes Exclusive Supply Agreement with Global Pharma Company"....
- [10] Teva Pharmaceutical Industries Ltd.. (11/27/17). "Press Release: Teva Announces New Organization Structure and Leadership Changes". Jerusalem....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top